Constipation, a common clinical condition, often presents a diagnostic and management challenge to clinicians. This condition, characterized by infrequent bowel movements, hard stools, straining during defecation, and a sensation of incomplete evacuation, is often a symptom of underlying gastrointestinal disorders. Therefore, a comprehensive approach is essential for effective diagnosis and management.
Diagnosis begins with a thorough patient history and physical examination. The Rome IV criteria, which includes infrequent bowel movements, hard stools, and straining, can be used as a diagnostic tool. In some cases, additional diagnostic tests such as blood tests, colonoscopy, or radiographic studies may be necessary to exclude other conditions such as colorectal cancer, inflammatory bowel disease, or thyroid dysfunction.
Management of constipation involves both non-pharmacological and pharmacological approaches. Lifestyle modifications including increased dietary fiber intake, regular physical activity, and adequate hydration are the first line of treatment. If these measures are ineffective, pharmacological interventions such as laxatives, stool softeners, and prokinetic agents can be considered. In refractory cases, newer therapies such as biofeedback and sacral nerve stimulation may be explored.
Despite the availability of various treatment options, many patients continue to suffer from constipation due to inadequate response to therapy, side effects, or lack of long-term efficacy. Therefore, there is a need for more effective and safer therapeutic options. Emerging therapies such as peripherally acting mu-opioid receptor antagonists and guanylate cyclase-C agonists show promise and may change the landscape of constipation management in the future.
Constipation is a complex clinical condition requiring a comprehensive approach for effective diagnosis and management. Clinicians should remain abreast of the latest diagnostic criteria and management strategies, including emerging therapies, to provide optimal care to their patients.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation